This activation was found to rely on epigenetic modifications of the VWF gene promotor, as investigated in tumor cell lines by Mojiri et al. Several studies on the VWF-expressing osteosarcoma cell line Saos2 and glioma cell lines displayed a transcription factor binding pattern similar to the pattern found in active VWF promoters of ECs. The gene discussed is VWF; the disease is glioma.